Evidence map›Paper›PMID 28902773›Full record

ArticleTransplantation2018

Reduced TCR Signaling Contributes to Impaired Th17 Responses in Tolerant Kidney Transplant Recipients.

Estefania Nova-Lamperti, Marco Romano, Sofia Christakoudi, Manohursingh Runglall, Reuben McGregor, Paula Mobillo, Yogesh Kamra, Tjir-Li Tsui, Sonia Norris, Susan John and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Transplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. CD4Frontiers in immunology · 2022
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Estefania Nova-LampertiMRC Centre for Transplantation, King's College London, London, United Kingdom.
Marco RomanoMRC Centre for Transplantation, King's College London, London, United Kingdom.
Sofia ChristakoudiMRC Centre for Transplantation, King's College London, London, United Kingdom.
Manohursingh RunglallNIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' Hospital.
Reuben McGregorMRC Centre for Transplantation, King's College London, London, United Kingdom.
Paula MobilloMRC Centre for Transplantation, King's College London, London, United Kingdom.
Yogesh KamraNIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' Hospital.
Tjir-Li TsuiNIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' Hospital.
Sonia NorrisMRC Centre for Transplantation, King's College London, London, United Kingdom.
Susan JohnDivision of Immunology, Infection & Inflammatory Disease, King's College London, London, United Kingdom.
Dominic A BoardmanMRC Centre for Transplantation, King's College London, London, United Kingdom.
Robert I LechlerMRC Centre for Transplantation, King's College London, London, United Kingdom.
Giovanna LombardiMRC Centre for Transplantation, King's College London, London, United Kingdom.
Maria P Hernandez-FuentesMRC Centre for Transplantation, King's College London, London, United Kingdom.
www.GAMBITstudy.co.uk
King's College London · GB

Funding

British Heart Foundation RG/08/005/25303British Heart Foundation RG/13/12/30395Medical Research Council G0801537Medical Research Council MC_PC_14105Medical Research Council MR/J006742/1Medical Research Council MR/L022699/1
6 · The paper itself

Abstract

backgroundThe development of spontaneous kidney transplant tolerance has been associated with numerous B cell-related immune alterations. We have previously shown that tolerant recipients exhibit reduced B-cell receptor signalling and higher IL-10 production than healthy volunteers. However, it is unclear whether cluster of differentiation (CD)4 T cells from tolerant recipients also display an anti-inflammatory profile that could contribute to graft maintenance.

methodsCD4 T cells were isolated from kidney transplant recipients who were identified as being tolerant recipients, patients with chronic rejection or healthy volunteers. CD4 T cells from the 3 groups were compared in terms of their gene expression profile, phenotype, and functionally upon activation.

resultsGene expression analysis of transcription factors and signalling proteins, in addition to surface proteins expression and cytokine production, revealed that tolerant recipients possessed fewer Th17 cells and exhibited reduced Th17 responses, relative to patients with chronic rejection or healthy volunteers. Furthermore, impaired T-cell receptor signalling and altered cytokine cooperation by monocytes contributed to the development of Th17 cells in tolerant recipients.

conclusionsThese data suggest that defective proinflammatory Th17 responses may contribute to the prolonged graft survival and stable graft function, which is observed in tolerant recipients in the absence of immunosuppressive agents.

Indexed as

Kidney TransplantationTransplantation ToleranceAdultAgedCD4-Positive T-LymphocytesCell LineageExtracellular Signal-Regulated MAP KinasesFemaleHumansInterleukin-6MaleMiddle AgedReceptors, Antigen, T-CellSignal TransductionTh17 CellsExtracellular Signal-Regulated MAP KinasesInterleukin-6Receptors, Antigen, T-Cell

Identifiers

PMID28902773
PMCPMC5737900
OpenAlexW2755166820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.